Angela DeMichele
Affiliations: | Epidemiology and Biostatistics | University of Pennsylvania, Philadelphia, PA, United States |
Area:
EpidemiologyGoogle:
"Angela DeMichele"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Magbanua MJM, Ahmed Z, Sayaman RW, et al. (2024) Cell-free DNA concentration as a biomarker of response and recurrence in HER2-negative breast cancer receiving neoadjuvant chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Lawrence-Paul MR, Pan TC, Pant DK, et al. (2024) Rare subclonal sequencing of breast cancers indicates putative metastatic driver mutations are predominately acquired after dissemination. Genome Medicine. 16: 26 |
| Smith KL, Zhao F, Mayer IA, et al. (2024) Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131. Cancer |
| Kyalwazi B, Yau C, Campbell MJ, et al. (2023) Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer. Jama Network Open. 6: e2349646 |
| Albain KS, Yau C, Petricoin EF, et al. (2023) Neoadjuvant trebananib plus paclitaxel-based chemotherapy for stage II/III breast cancer in the adaptively randomized I-SPY2 trial - Efficacy and biomarker discovery. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Gallagher RI, Wulfkuhle J, Wolf DM, et al. (2023) Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial. Cell Reports. Medicine. 101312 |
| Pfeiler G, Hlauschek D, Mayer EL, et al. (2023) Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300126 |
| DeMichele A, Robert N, Chen C, et al. (2023) Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast Cancer. Targeted Oncology |
| Burstein HJ, DeMichele A, Somerfield MR, et al. (2023) Testing for Mutations to Guide Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300638 |
| Magbanua MJM, Brown Swigart L, Ahmed Z, et al. (2023) Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy. Cancer Cell |